Page last updated: 2024-10-23

berberine and Lymphoma, Large B-Cell, Diffuse

berberine has been researched along with Lymphoma, Large B-Cell, Diffuse in 3 studies

Lymphoma, Large B-Cell, Diffuse: Malignant lymphoma composed of large B lymphoid cells whose nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation.

Research Excerpts

ExcerptRelevanceReference
" Here, in diffuse large B-cell lymphoma (DLBCL), serum metabolomic analysis revealed that oncogenic MYC could induce aberrant choline metabolism by transcriptionally activating the key enzyme phosphate cytidylyltransferase 1 choline-α (PCYT1A)."7.85MYC is a positive regulator of choline metabolism and impedes mitophagy-dependent necroptosis in diffuse large B-cell lymphoma. ( Chen, SJ; Fei, XC; Gale, RP; Janin, A; Jiang, XF; Li, B; Wang, CF; Wang, L; Xiong, J; Zhao, WL; Zhao, Y; Zheng, Z, 2017)
" Here, in diffuse large B-cell lymphoma (DLBCL), serum metabolomic analysis revealed that oncogenic MYC could induce aberrant choline metabolism by transcriptionally activating the key enzyme phosphate cytidylyltransferase 1 choline-α (PCYT1A)."3.85MYC is a positive regulator of choline metabolism and impedes mitophagy-dependent necroptosis in diffuse large B-cell lymphoma. ( Chen, SJ; Fei, XC; Gale, RP; Janin, A; Jiang, XF; Li, B; Wang, CF; Wang, L; Xiong, J; Zhao, WL; Zhao, Y; Zheng, Z, 2017)
" In this study, we employed the CCK8 assay to reveal that DCZ0358 inhibited proliferation in a dependent manner of time and dosage of DLBCL cells."1.91Berberine derivative DCZ0358 induce oxidative damage by ROS-mediated JNK signaling in DLBCL cells. ( Feng, Q; Gao, X; Hu, H; Hu, K; Jia, X; Li, B; Lu, Y; Peng, Y; Shi, J; Song, D; Wang, G; Wu, X; Xu, Z; Yi, H; Zhang, H; Zhang, Q; Zhu, H; Zhu, W, 2023)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Feng, Q1
Hu, K1
Hu, H1
Lu, Y1
Zhang, H1
Wang, G1
Zhang, Q1
Xu, Z1
Gao, X1
Jia, X1
Zhu, H1
Song, D1
Yi, H1
Peng, Y1
Wu, X1
Li, B2
Zhu, W1
Shi, J1
Ren, S1
Cai, Y1
Hu, S1
Liu, J1
Zhao, Y2
Ding, M1
Chen, X1
Zhan, L1
Zhou, X1
Wang, X1
Xiong, J1
Wang, L1
Fei, XC1
Jiang, XF1
Zheng, Z1
Wang, CF1
Chen, SJ1
Janin, A1
Gale, RP1
Zhao, WL1

Other Studies

3 other studies available for berberine and Lymphoma, Large B-Cell, Diffuse

ArticleYear
Berberine derivative DCZ0358 induce oxidative damage by ROS-mediated JNK signaling in DLBCL cells.
    International immunopharmacology, 2023, Volume: 125, Issue:Pt A

    Topics: Apoptosis; Berberine; Cell Line, Tumor; Humans; JNK Mitogen-Activated Protein Kinases; Lymphoma, Lar

2023
Berberine exerts anti-tumor activity in diffuse large B-cell lymphoma by modulating c-myc/CD47 axis.
    Biochemical pharmacology, 2021, Volume: 188

    Topics: Adult; Aged; Animals; Antineoplastic Agents; Berberine; CD47 Antigen; Genes, myb; Humans; Lymphoma,

2021
MYC is a positive regulator of choline metabolism and impedes mitophagy-dependent necroptosis in diffuse large B-cell lymphoma.
    Blood cancer journal, 2017, 07-07, Volume: 7, Issue:7

    Topics: Berberine; Cell Line, Tumor; Choline; Choline-Phosphate Cytidylyltransferase; Humans; Lymphoma, Larg

2017